Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Market quiet, Nifty futures subdued, Asian markets lower. Analysts predict benefits for Indian contract manufacturers from ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

GLP-1 inhibitors can manage blood sugar levels in diabetes patients and aid weight loss - and one expert claims there are ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

When looking for a high-protein snack that supports gut health, there are some snacks that check both of those boxes. When we ...

Weight loss injections are now available on the NHS but experts warn thousands of patients may be vulnerable to serious side ...

Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies ...

On Saturday, the Juice hitmaker took to Instagram to share a video of herself modeling a sexy piece of swimwear from her ...